Collegium Pharmaceutical (COLL) Notes Payables (2014)
Collegium Pharmaceutical (COLL) posted quarterly Notes Payables of $5.0 million for Q4 2014.
Collegium Pharmaceutical (COLL) Notes Payables (2014) Analysis & Trends
Collegium Pharmaceutical's Notes Payables history runs 1 years deep, the most recent figure standing at $5.0 million for Q4 2014.
- In Q4 2014, Notes Payables changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2014 stood at $5.0 million (changed N/A YoY), while the FY2014 annual figure was $5.0 million, changed N/A from the prior year.
- Notes Payables for Q4 2014 stood at $5.0 million.
- The five-year high for Notes Payables was $5.0 million in Q4 2014, with the low at $5.0 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 5.00 Mn |